TransDigm (TDG) Tops Q1 EPS by 17c, Raises FY12 Guidance
Tweet
Share
E-mailGet Alerts TDG Hot Sheet
Price: $1,150.32 -1.01%
Revenue Growth %: +20.5%
Financial Fact:
NET SALES: 875.22M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +20.5%
Financial Fact:
NET SALES: 875.22M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
TransDigm (NYSE: TDG) reported Q1 EPS of $1.42, $0.17 better than the analyst estimate of $1.25. Revenue for the quarter came in at $352.5 million versus the consensus estimate of $345.76 million.
TransDigm sees FY2012 EPS of $5.66-$6.00, versus prior guidance of $5.35-$5.67 and the consensus of $5.58. TransDigm sees FY2012 revenue of $1.47-$1.51 billion, versus prior guidance of $1.43-$1.47 billion and the consensus of $1.47 billion.
For earnings history and earnings-related data on TransDigm (TDG) click here.
TransDigm sees FY2012 EPS of $5.66-$6.00, versus prior guidance of $5.35-$5.67 and the consensus of $5.58. TransDigm sees FY2012 revenue of $1.47-$1.51 billion, versus prior guidance of $1.43-$1.47 billion and the consensus of $1.47 billion.
For earnings history and earnings-related data on TransDigm (TDG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Bernstein SocGen Group Reiterates Outperform Rating on Robinhood Markets (HOOD)
- Labcorp acquires MLM Medical Labs to expand lab network
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
